Merck is building a $3 billion pharmaceutical facility in the U.S
On October 20th, Merck announced the construction of a pharmaceutical facility at its plant in Elkton, Virginia, USA, at a cost of $3 billion. The statement said that this investment is part of Merck's more than $70 billion investment in expanding domestic production and research and development in the United States this year
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments